Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience.
The Breast(2016)
摘要
•EVE and EXE combination represents a novel therapy for advanced breast cancer.•Evaluations of toxicities in unselected patients are of interest.•Retrospective analysis in unselected patients has been conducted.•No association between toxicity and previous treatments has been found.
更多查看译文
关键词
Everolimus,Metastatic breast cancer,Exemestane
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络